the aid library

Harmonization of community health worker programs for HIV: A four-country qualitative study in Southern Africa

J.-W. De Neve; H. Garrison-Desany; K. G. Andrews; et al. PLOS Medicine (2017) CC

Research Article PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002374 August 8, 2017

Introduction to HIV, AIDS and Sexually Transmitted Infection Surveillance - Overview of the HIV/AIDS Epidemic with an Introduction to Public Health Surveillance

United States Department of Health and Human Services; Centers for Disease Control and Prevention (HHS-CDC); Global AIDS Program (GAP); et al. United States Department of Health and Human Services; Centers for Disease Control and Prevention (HHS-CDC); Global AIDS Program (GAP); et al. (2011) C2

Participant Manual February 2011 Edition 3.0

Children affected by HIV/AIDS in South Africa

R. Smart; HIVAIDS Consultant Save the Children (UK) South Africa Programme; The Department of Social Development (2003) C2

A Rapid Appraisal of Priorities, Policies and Practices

ECDC/EFSA/EMA second joint report on the integratedanalysis of the consumption of antimicrobial agents andoccurrence of antimicrobial resistance in bacteria fromhumans and food-producing animals

European Centre for Disease Prevention and Control (ECDC), European Food Safety Authority (EFSA) andEuropean Medicines Agency (EMA) (2017) C_CDC

The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp... more

Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries

Reusken C. B. E. M., E. K. Broberg, B. Haagmans et al. Eurosurveillance (2020) C2

Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-... more

Antimicrobial resistance in the Asia Pacific region: a development agenda

World Health Organization WHO (2017) C_WHO

Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po... more

Resource mobilisation for AMR: Getting AMR into plans and budgets of government and development partners / Nepal country report

World Health Organization WHO (2018) C_WHO

Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.

Клиническое ведение тяжелой острой респираторной инфекции при подозрении на коронавирусную инфекцию COVID-19

World Health Organization WHO (2020) C_WHO

Временные рекомендации 13 марта 2020 г. Настоящий документ является вторым изданием руководства (версия 1.2), которое первоначально представляло собой адаптированн... more

Q&A: Antibiotic resistance: where does it come from and what can we do about it?

Wright G.D. BMC Biology (2010) C2

Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-... more

Young doctors’ perspectives on antibiotic use and resistance: a multinational and inter-specialty cross-sectional European Society of Clinical Microbiology and Infectious Diseases (ESCMID) survey

Beovic B., M. Dousak, C. Pulcini et al. Oxford University Press (2019) C2

Antibiotic resistance has been recognized as a major global health threat and optimizing prescribing is one of the most effective measures to preserve the effectiveness of antibiotics. The quality of prescribing depends mostly on those prescribers belonging to clinical medical specialties... more

The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients

Gyssens I. C., W. V. Kern, D. M. Livermore Haematologica (2013) C2

Haematologica has published European guidelines for empirical and targeted antibacterial therapy forfebrile neutropenic patients in the era of emerging resistance (ECIL-4). Indeed, collateral damage by broad-spectrum antibiotic therapy includes selection of multidrugresistant pathogens, and incr... more

Guidelines on Clinical Management of COVID – 19

Government of India Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division) Government of India Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division) (2020) C2

17th March 2020

cobas®SARS-CoV-2

Cobas (2020) C1

Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use

Guidelines on Clinical management of severe acute respiratory illness (SARI) in suspect/confirmed novel coronavirus (nCoV) cases

National Centre for Disease Control (formerly National Institute of Communicable Diseases) National Centre for Disease Control (formerly National Institute of Communicable Diseases) (2020) C2

Accessed: 16.04.2020

Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended

World Health Organization WHO (2021) C_WHO

interim guidance, 14 June 2021 This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases... more

What you need to know about HIV and COVID-19 in the context of human mobility

ONUSIDA; Response for Venezuelans (R4V) (2020) C2

COVID-19 is a disease caused by a new strain of coronavirus, a new coronavirus associated with the severe acute respiratory syndrome (SARS) viruses family and some coronaviruses associated with common cold. There is still no evidence that persons living with HIV have a higher risk of contracting CO... more

COVID Reference 2021.6 EN
recommended

Kamps, B.S.; Camp, R. and C. Hoffmann (2021) CC

Guidance for the prevention of COVID-19 infections among high-risk individuals in urban settings

Caroline Favas London School of Hygiene and Tropical Medicine (2020) C2

This document provides guidance on the implementation of the shielding approach in urban areas in LICs and crisis-affected regions. It is intended for the community itself, national and local governance institutions, and humanitarian and development actors operating in the country.